<?xml version='1.0' encoding='utf-8'?>
<document id="25738002"><sentence text="Oxcarbazepine induced maculopapular rash - a case report."><entity charOffset="0-13" id="DDI-PubMed.25738002.s1.e0" text="Oxcarbazepine" /></sentence><sentence text="Unlike carbamazepine, newer anti epileptic drug like oxcarbazepine, reports fewer side effects"><entity charOffset="7-20" id="DDI-PubMed.25738002.s2.e0" text="carbamazepine" /><entity charOffset="53-66" id="DDI-PubMed.25738002.s2.e1" text="oxcarbazepine" /><pair ddi="false" e1="DDI-PubMed.25738002.s2.e0" e2="DDI-PubMed.25738002.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25738002.s2.e0" e2="DDI-PubMed.25738002.s2.e1" /></sentence><sentence text=" In this report we describe a case of oxcarbazepine induced maculopapular rash probably happened because of a drug interaction with isoniazid, and a brief review of the existing literature is presented herewith"><entity charOffset="38-51" id="DDI-PubMed.25738002.s3.e0" text="oxcarbazepine" /><entity charOffset="132-141" id="DDI-PubMed.25738002.s3.e1" text="isoniazid" /><pair ddi="false" e1="DDI-PubMed.25738002.s3.e0" e2="DDI-PubMed.25738002.s3.e0" /><pair ddi="false" e1="DDI-PubMed.25738002.s3.e0" e2="DDI-PubMed.25738002.s3.e1" /></sentence><sentence text=" A 40-year-old male patient received oxcarbazepine 300mg twice daily along with other anti-tubercular drugs including isoniazid (300mg) once daily since two days"><entity charOffset="37-50" id="DDI-PubMed.25738002.s4.e0" text="oxcarbazepine" /><entity charOffset="118-127" id="DDI-PubMed.25738002.s4.e1" text="isoniazid" /><pair ddi="false" e1="DDI-PubMed.25738002.s4.e0" e2="DDI-PubMed.25738002.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25738002.s4.e0" e2="DDI-PubMed.25738002.s4.e1" /></sentence><sentence text=" Extensive cutaneous rash with intense itching developed which subsided on discontinuation of oxcarbazepine"><entity charOffset="94-107" id="DDI-PubMed.25738002.s5.e0" text="oxcarbazepine" /></sentence><sentence text=" This case highlights the fact that there is a potential possibility of drug-drug interaction between oxcarbazepine and isoniazid and concomitant use of these two drugs should better be avoided during clinical practice"><entity charOffset="102-115" id="DDI-PubMed.25738002.s6.e0" text="oxcarbazepine" /><entity charOffset="120-129" id="DDI-PubMed.25738002.s6.e1" text="isoniazid" /><pair ddi="false" e1="DDI-PubMed.25738002.s6.e0" e2="DDI-PubMed.25738002.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25738002.s6.e0" e2="DDI-PubMed.25738002.s6.e1" /></sentence><sentence text=" " /></document>